Apellis Pharmaceuticals, Inc. (FRA:1JK)
Germany · Delayed Price · Currency is EUR 18.50
-0.04 (-0.21%)
At close: Jan 30, 2026
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.4 billion as of January 30, 2026. Its market cap has decreased by -31.48% in one year.
Market Cap
2.40B
Enterprise Value
2.40B
Revenue
866.28M
Ranking
n/a
PE Ratio
62.72
Stock Price
€18.50
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.40B, an increase of 304.99%. That is a compound annual growth rate of 18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.40B | -11.17% |
| Dec 31, 2025 | 2.71B | -29.40% |
| Dec 31, 2024 | 3.83B | -40.26% |
| Dec 29, 2023 | 6.42B | 19.95% |
| Dec 30, 2022 | 5.35B | 32.19% |
| Dec 31, 2021 | 4.05B | 14.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |